Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer

• Matteo Allegretti,
• Alessandra Fabi,
• Elena Giordani,
• Cristiana Ercolani,
• Paolo Romania,
• Cecilia Nisticò,
• Simona Gasparro,
• Vittoria Barberi,
• Maria Ciolina,
• Edoardo Pescarmona,
• Diana Giannarelli,
• Gennaro Ciliberto,
• Francesco Cognetti,
• Patrizio Giacomini

Affiliations

Matteo Allegretti

Oncogenomics and Epigenetics, IRCSS Regina Elena National Cancer Institute

Alessandra Fabi

Medical Oncology 1, IRCSS Regina Elena National Cancer Institute

Elena Giordani

Oncogenomics and Epigenetics, IRCSS Regina Elena National Cancer Institute

Cristiana Ercolani

Pathology, IRCSS Regina Elena National Cancer Institute

Paolo Romania

Oncogenomics and Epigenetics, IRCSS Regina Elena National Cancer Institute

Cecilia Nisticò

Medical Oncology 1, IRCSS Regina Elena National Cancer Institute

Simona Gasparro

Medical Oncology 1, IRCSS Regina Elena National Cancer Institute

Vittoria Barberi

Specialization School in Oncology, Sapienza University of Rome

Maria Ciolina

Radiology and Diagnostic Imaging, IRCSS Regina Elena National Cancer Institute

Edoardo Pescarmona

Pathology, IRCSS Regina Elena National Cancer Institute

Diana Giannarelli

Biostatistical Unit, IRCSS Regina Elena National Cancer Institute

Gennaro Ciliberto

Scientific Direction, IRCSS Regina Elena National Cancer Institute

Francesco Cognetti

Clinical and Molecular Medicine, Sapienza University of Rome

Patrizio Giacomini

Oncogenomics and Epigenetics, IRCSS Regina Elena National Cancer Institute